News & Media

May 18, 2022

Biosimilar medicines are potentially less expensive than original biologics, whilst having the same effectiveness. Meet Cory Wohlbach, who is responsible for steering Teva’s new biosimilar products through the regulatory approval process. Here he explains how biosimilars have the potential to reduc...

May 17, 2022

Meet Samuel Frere and Elena Lapkina Gendler, scientists who work in the non-clinical (early stage) research lab in Netanya, Israel. Their work allows their group to test the effect of Teva drugs on gene expression and on cellular function. While they took very different paths to get there, both...

May 16, 2022

Last week we hosted Association for Accessible Medicines (AAM) at our Parsippany, NJ HQ as a part of their Generics Are the Solution tour. On this tour AAM is on the road visiting with generic and biosimilar drugmakers across the country to share the work the association is doing as well as learn mo...

May 16, 2022

At Teva, we know that providing medicines is an important job—and conducting business ethically and responsibly is non-negotiable. In 2021, we trained 20,000+ employees on ethics (99.6% of those assigned), published three new position statements on patient safety, responsible supply chain and risk m...

May 15, 2022

When most of us think about becoming parents, we picture sunlit afternoons chasing our toddlers through the park, birthday parties, vacations, and school sports days. We often don't envision how difficult parenting can be when coping with the pain, fatigue, hospital appointments, and diagnoses that...

May 12, 2022

What does family mean to you? For many of us, no words could encompass the emotional, developmental, and spiritual importance of family life. Family is about love. It's about understanding, hope, comfort, advice, and encouragement. We treasure the people on our home team through the good times and t...

May 11, 2022

In collaboration with Morehouse School of Medicine, we conducted a survey on the State of Access to Healthcare in America. Our findings show that we must take action to address #healthcare barriers within our communities. Read our survey findings here to learn more here: https://bit.ly/3l009Dv #Pat...

May 11, 2022

Yesterday we had the pleasure of hosting the Teva satellite event "Challenges & Opportunities in CNS Drug Discovery" at the 2022 Biomed conference. Thank you to all the participants, the room was full of unique energy. We learned about multidisciplinary efforts to advance this complex field such as...

May 09, 2022

Further unlocking the value of critical medicines with biosimilars is an important frontier in drug development. It offers patients safe and effective treatment options through more affordable alternatives to branded biological products that have lost their exclusivity rights.  Accelerating patient...

May 05, 2022

Supporting patient lives and healthcare systems: we’re using Artificial Intelligence (AI) and advanced analytics to improve the drug development process and help provide medicines for patients with various conditions such as schizophrenia, depression, Parkinson’s and Chronic Obstructive Pulmonary Di...